HNN3.0
Register
Register
Register

Project cooperationUpdated on 23 February 2026

Mathematical T-cell modeller seeks project.

Associate Professor at University of Antwerp

Antwerp, Belgium

About

Our CHERMID group has a decades-long experience with mathematical modeling and in particular with mathematical modeling of immune responses.

We are in particular specialized in modeling longitudinal T-cell and antibody responses using different modeling approaches.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Type

  • Partner seeks Consortium/Coordinator

Organisation

University of Antwerp

University

Antwerp, Belgium

Similar opportunities

  • Project cooperation

    New in vitro assay methodologies

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Hanne Haslene-Hox

    Seinor research scientist at SINTEF Industry

    Trondheim, Norway

  • Project cooperation

    Modelling of Disease and Treatment

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Gil Katz

    Manager, Medical-Computational Collaborations at Institute for Medical BioMathematics (IMBM)

    Bene Ataroth, Israel

  • Project cooperation

    Computational prognosis of therapies for solid tumors

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Gianpaolo Ruocco

    Professor and CEO at initiatives for Bio-Materials Behavior (iBMB) Srls

    Potenza, Italy